|Krüppel-like factor 4 regulates intestinal epithelial cell morphology and polarity.|
|Jump to Full Text|
|PMID: 22384261 Owner: NLM Status: MEDLINE|
|Krüppel-like factor 4 (KLF4) is a zinc finger transcription factor that plays a vital role in regulating cell lineage differentiation during development and maintaining epithelial homeostasis in the intestine. In normal intestine, KLF4 is predominantly expressed in the differentiated epithelial cells. It has been identified as a tumor suppressor in colorectal cancer. KLF4 knockout mice demonstrated a decrease in number of goblet cells in the colon, and conditional ablation of KLF4 from the intestinal epithelium led to altered epithelial homeostasis. However, the role of KLF4 in differentiated intestinal cells and colon cancer cells, as well as the mechanism by which it regulates homeostasis and represses tumorigenesis in the intestine is not well understood. In our study, KLF4 was partially depleted in the differentiated intestinal epithelial cells by a tamoxifen-inducible Cre recombinase. We found a significant increase in the number of goblet cells in the KLF4-deleted small intestine, suggesting that KLF4 is not only required for goblet cell differentiation, but also required for maintaining goblet cell numbers through its function in inhibiting cell proliferation. The number and position of Paneth cells also changed. This is consistent with the KLF4 knockout study using villin-Cre . Through immunohistochemistry (IHC) staining and statistical analysis, we found that a stem cell and/or tuft cell marker, DCAMKL1, and a proliferation marker, Ki67, are affected by KLF4 depletion, while an enteroendocrine cell marker, neurotensin (NT), was not affected. In addition, we found KLF4 depletion altered the morphology and polarity of the intestinal epithelial cells. Using a three-dimensional (3D) intestinal epithelial cyst formation assay, we found that KLF4 is essential for cell polarity and crypt-cyst formation in human colon cancer cells. These findings suggest that, as a tumor suppressor in colorectal cancer, KLF4 affects intestinal epithelial cell morphology by regulating proliferation, differentiation and polarity of the cells.|
|Tianxin Yu; Xi Chen; Wen Zhang; Juan Li; Ren Xu; Timothy C Wang; Walden Ai; Chunming Liu|
|Type: Journal Article; Research Support, N.I.H., Extramural Date: 2012-02-24|
|Title: PloS one Volume: 7 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2012|
|Created Date: 2012-03-02 Completed Date: 2012-08-27 Revised Date: 2013-06-26|
Medline Journal Info:
|Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States|
|Languages: eng Pagination: e32492 Citation Subset: IM|
|Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.|
|APA/MLA Format Download EndNote Download BibTex|
Chromosomes, Artificial, Bacterial
Colonic Neoplasms / metabolism
DNA, Complementary / metabolism
Epithelial Cells / cytology*
Gene Expression Regulation, Neoplastic*
Immunohistochemistry / methods
Intestinal Neoplasms / metabolism
Intestines / cytology*
Kruppel-Like Transcription Factors / metabolism, physiology*
|R01 DK071976/DK/NIDDK NIH HHS|
|0/DNA, Complementary; 0/GKLF protein; 0/Kruppel-Like Transcription Factors|
Journal ID (nlm-ta): PLoS One
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Publisher: Public Library of Science, San Francisco, USA
Yu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received Day: 24 Month: 8 Year: 2011
Accepted Day: 27 Month: 1 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 24 Month: 2 Year: 2012
Volume: 7 Issue: 2
E-location ID: e32492
PubMed Id: 22384261
Publisher Id: PONE-D-11-16504
|Krüppel-like Factor 4 Regulates Intestinal Epithelial Cell Morphology and Polarity Alternate Title:KLF4 Regulates Intestinal Cell Morphology|
|Timothy C. Wang5|
|Neil A. Hotchinedit1||
1Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America
2Department of Biological and Molecular Biochemistry, University of Texas Medical Branch, Galveston, Texas, United States of America
3Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States of America
4Department of Pharmacology and Toxicology, University of Kentucky, Lexington, Kentucky, United States of America
5Division of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Center, Columbia University, New York, New York, United States of America
6Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, United States of America
|University of Birmingham, United Kingdom
|Correspondence: * E-mail: email@example.com
Contributed by footnote: Conceived and designed the experiments: TY RX CL. Performed the experiments: TY XC WZ JL. Analyzed the data: TY. Contributed reagents/materials/analysis tools: TW WA. Wrote the paper: TY CL.
Colorectal cancer is the second most commonly diagnosed cancer among men and women and the second leading cause of cancer deaths in the United States , . Different genetic variations could lead to abnormal epithelial development and polyp formation, which could be further induced to progression of colorectal carcinomas . Wnt signaling plays an important role in early stages of colorectal carcinogenesis; abnormality in the gene APC or β-catenin leads to aberrant crypt formation , . Mutations in other oncogenes and tumor suppressor genes, such as K-ras and p53, also contribute to colorectal carcinogenesis .
KLF4 is a zinc finger transcription factor initially found to be enriched in the epithelium of intestine and skin , . Later, it was found in a variety of other tissues, such as thymus, cornea, cardiac myocytes and lymphocytes , , , . KLF4 plays an important role in development and cell differentiation , , . In normal intestine, KLF4 is predominantly expressed in differentiated epithelial cells near the luminal surface and goblet cells in the crypts , . KLF4 is down-regulated in colorectal cancers and has been identified as a tumor suppressor , , . As one of the four factors that induce pluripotent stem cells, KLF4 plays a role in cell fate reprogramming and self-renewal of embryonic stem (ES) cells , . The roles of KLF4 in differentiated intestinal cells are not well understood.
Mice homozygous for a null mutation in KLF4 had defects in terminal differentiation of goblet cells, while further study of KLF4 in mouse intestine was hampered due to early lethality of mutant mice . Using Villin-Cre recombinase system, another study found that conditional ablation of KLF4 from the intestinal epithelium led to failure of goblet cell differentiation , which also highlights the role of KLF4 in maintaining intestinal epithelial morphology and homeostasis. Interestingly, depletion of KLF4 from two-week-old mice using vil-CreER, an inducible Cre recombinase, had no effect on goblet cell differentiation . The discrepancy may be due to differential expression of the villin gene in early and later stages of gut development . In this study, we analyzed the role of KLF4 in the adult intestine using an inducible Cre recombinase, which is driven by native promoter of KLF4.
In order to test the function of KLF4 in adult intestinal epithelium cells, we generated inducible KLF4 knockout (Klf4−/−) mice, which are KLF4/CreER (+/−) and KLF4(flox/flox) double transgenic. The Cre recombinase cDNA fused with tamoxifen-inducible estrogen receptor gene was inserted into BAC clone at the initiating methionine of KLF4 gene. Thus, the expression of Cre recombinase is driven by the KLF4 promoter in transgenic mice. Induction of KLF4/CreER (+/−) and KLF4(flox/flox) double transgene with tamoxifen led to activation of Cre recombinase. The KLF4 function in the skin was studied using this mouse model. KLF4 depletion resulted in a significant increase of hair follicle density, as well as changes of suprabasal cells from a single layer into multiple layers, which is indicating an inhibitory role of KLF4 in proliferation of mouse skin keratinocytes . In the small intestine, the Cre recombinase was predominantly expressed in the top of the villus, and which is recapitulating expression pattern of endogenous KLF4 (Fig. 1A). Tamoxifen-mediated Cre recombinase activation resulted in partial depletion of KLF4 when compared with non-induced transgenic mice (Fig. 1A).
Haematoxylin and eosin (H&E) staining results indicated an increase in the number of secretory cells in Klf4−/− intestine; the position of these cells appeared to be dislocated compared with control intestine (Fig. 1B). To analyze the effects of KLF4 depletion on goblet cells, which are one of the secretory cell lineages in the small intestine, tissue sections were stained with both Periodic acid-Schiff (PAS) and Alcian Blue (AB), respectively (Fig. 1C left panel). An enlargement in size and an increase in the numbers of PAS and AB positive cells indicated an increase in goblet cell proliferation in small intestine of Klf4−/− mice (Fig. 1C right panel), which highlights the role of KLF4 in maintaining numbers of goblet cells in mature small intestine. Time point-specific changes in number of PAS positive cells due to tamoxifen treatment further indicated that KLF4 is critical for goblet cell number maintenance (Fig. 2A). It is worth noticing that our result is distinct from the finding that KLF4 knockout leads to loss of Goblet cells in the colon , and that conditional ablation of KLF4 also leads to loss of goblet cells in the intestinal epithelium . The difference is due to the stage of KLF4 knockout before or after goblet cell differentiation. KLF4 depletion had no effect on neuroendocrine cells, as indicated by immunofluorescent staining for neurotensin (NT) (Fig. 1D), suggesting that function of KLF4 in small intestine is cell type-specific.
In order to further examine the role of KLF4 in intestinal epithelial cells, the morphology change was analyzed in Klf4−/− mice compared with non-induced (Day 0) mice by H&E staining (Fig. 2A): The average length of the crypt-villus axis was increased in Klf4−/− mouse intestine (Fig. 2A, 2B). The number of secretory-like cells is increased; these cells either have larger volume of vacuoles or contain secreted granules like Paneth cells (Fig. 2A). A large number of cell nuclei lost apical-basolateral polarity, which is typical of the wild-type enterocytes. Instead of a monolayer of well-oriented epithelial cells, Klf4−/− intestine had multiple layers of disorganized cells (Fig. 2A, C). Positions of the secretory cells were changed; instead of sitting at the bottom of the crypt, the granule-containing cells dislocated upward in the crypts (Fig. 2A, C). In order to confirm that the morphology change was not due to tamoxifen treatment, small intestine from wild-type (WT) mice treated with tamoxifen was stained as a control; they showed a normal morphology as non-treated transgenic mice.
The cell proliferation marker Ki67 was analyzed by IHC. The average length of Ki67+ region along the crypt-villus axis, as well as numbers of Ki67+ cells increased (Fig. 2A–C), i.e., proliferation compartment of the intestine was expanded, indicating an increase in proliferation capacity in Klf4−/− mouse intestine. PCNA is another proliferation marker; and its change in response to KLF4 loss is consistent with the results from Ki67 staining (Fig. 2A). This further highlights the role of KLF4 in inhibiting intestine proliferation.
In addition to goblet cell staining, the role of KLF4 in intestinal cell proliferation was confirmed by staining for other cell types including Paneth cells and tuft cells. Tissue slides from both normal and Klf4−/− intestine were stained for lysozyme, which is a marker for Paneth cells (Fig. 2A and C). A larger proportion of cells stained positive for lysozyme in small intestine from Klf4−/− mice compared with control mice, and these cells were dislocated through the crypt-villus axis, indicating that KLF4 loss also led to an increase in Paneth cell population and has an effect on position of these cells. This result re-emphasizes the role of KLF4 in controlling Paneth cells and strongly supports the finding from the KLF4 knockout study using villin Cre .
Based on the current model, small intestine is composed of the Paneth cell region (bottom of crypt), the stem cell zone (through +4 location), an amplification compartment (up to top of crypt) and a differentiation compartment (including crypt-villus junction) , . To further analyze the effect of KLF4 on intestinal homeostasis, tissue sections from Klf4−/− mouse intestine were stained for stem cell and/or tuft cell marker DCAMKL-1  (Fig. 2A–C). Surprisingly, DCAMKL-1 positive cells were increased in the Klf4−/− mouse small intestine along the villus, but were not restricted to the crypt base, indicating an increase in number of tuft cells due to loss of KLF4.
Based on our observation of changes in cell position as well as epithelial apical-basolateral morphology, we proposed that KLF4 is not only responsible for controlling cell differentiation and proliferation, but also cell polarity. As indicated by H&E staining, a great part of the cell nuclei lost polarity in Klf4−/− mouse small intestine. Paneth cells change their position due to depletion of KLF4. Meanwhile, most of the tuft cells that were positive for DCAMKL-1 also were out of direction in knockout mice (Fig. 2A, C). In order to investigate the role of KLF4 in regulating cell polarity, we generated a three-dimensional (3D) epithelial cyst formation assay for Caco-2 cells, in which the morphological structure of cyst and apical-basolateral cell polarity can be examined in vitro.
Normally, Caco-2 cells with high polarity form lumen-containing cysts in matrigel-based 3D culture and show apical-basolateral polarity as indicated by ZO-1 as a basolateral marker and α6-integrin as an apical marker, respectively (Fig. 3A, bottom; Fig. 3B, top); low- or no-polarity Caco-2 cells only form cysts without lumen (Fig. 3B, bottom). Staining of α6-integrin and ZO-1 for Caco-2 cells in 2D culture is shown as control, indicating non-polarization of Caco-2 cells in 2D growth conditions (Fig. 3A, top). To determine the role of KLF4 in lumen-cyst formation, KLF4 was depleted in Caco-2 cells by siRNA and shRNA delivery approaches, respectively (Fig. 3C and 3D left panels), followed by 3D formation assay. The number of lumen-cysts and total number of cysts were counted and the percentage of lumen-cyst was calculated to indicate the measure of cell polarity. We found that the efficiency of lumen-cyst formation was significantly reduced by siRNA and shRNA (Fig. 3C and 3D), suggesting that KLF4 is essential for cell polarity formation in the 3D culture of Caco-2 cells. To examine the role of KLF4 in apical-basolateral polarity in the intestine, we stained the knockout intestine tissues with ZO-1 antibody and found that KLF4 does regulate ZO-1 expression and distribution in the intestinal epithelial cells: instead of being highly expressed in the outer layer of epithelial cells surrounding the villus, KLF4 knockout intestine had overexpressed ZO-1 in multiple layers of villus (Figure 2C). This confirmed that KLF4 does not only regulate polarity formation of Caco-2 cells, it also regulates apical-basolateral polarity in intestinal epithelial cells.
In order to confirm the role of KLF4 in facilitating cell polarity formation, 3D culture assay was performed in another colon cancer cell line to test whether KLF4 can enhance cyst formation in vitro. The LS174T-KLF4 stable cell line expresses KLF4 upon doxycycline induction . LS174T cells seldom form cysts, even under 3D culture conditions. However, induction of KLF4 expression in LS174T cells significantly increased the chances of cyst formation in 3D culture (Fig. 4A, B), indicating that KLF4 indeed enhances cell polarity and thus facilitates cyst formation in 3D formation assay.
In order to address the mechanism by which KLF4 regulates cell polarity both in a knockout mouse model and in a 3D culture system, a panel of cell fate and polarity-related genes were analyzed by semi-quantitative RT-PCR. KLF4 was induced by doxycycline in LS174T-KLF4 colon cancer cells (Fig. 4C). Though we didn't see significant changes in DCAMKL-1 transcription, several polarity-related genes, LKB1, EPHB2, and EPHB3, were down-regulated. Intestinal stem cell markers LGR5 and CD44 were also down-regulated. As controls, the differentiation marker IAP and cell cycle inhibitor P21, which are known KLF4 target genes, were up-regulated by KLF4 (Fig. 4D). These findings suggest that KLF4 regulates epithelial cell polarity by regulating the transcription of multiple genes.
As an important regulator in intestinal cell differentiation during early development, KLF4 is also essential in maintaining normal homeostasis and morphology in adult intestine. Previous studies have deleted KLF4 in embryonic stages of mouse intestine; the terminal differentiation of goblet cells was decreased in these mice , . Here, we reported that in mature mouse intestine, partial depletion of KLF4 resulted in an increase in the number of goblet cells, indicating that KLF4 is required not only for goblet cell differentiation in early stages, but also for maintaining the number of differentiated goblet cells, probably by inhibiting cell proliferation. This is consistent with the observation that KLF4 is strongly expressed in goblet cells , , . We found that the average length of crypts was increased in KLF4-depleted small intestine, and the number of Ki67 positive cells was also increased. In agreement with previous findings, the number and position of Paneth cells had also changed . DCAMKL-1 is a marker for tuft cells, and a potential marker for quiescent intestinal stem cells , . We found that the number and position of DCAMKL-1 positive cells was also altered by KLF4 depletion. The changes in morphology and polarity of intestinal epithelial cells were confirmed by H&E staining. These data suggest that KLF4 plays a key role in maintaining normal intestinal homeostasis and morphology by regulating cell differentiation, proliferation and polarity. The roles of KLF4 in cell polarity were further analyzed in 3D culture, and several novel KLF4 target genes involved in cell differentiation and polarity were identified.
Our results suggest tamoxifen-induced knockout of KLF4 is advantageous in tissue- and stage-specificity. We were able to partially deplete KLF4 in the villi of small intestine, where KLF4 normally predominantly expresses. In addition, the inducible knockout strategy allows normal development of small intestine in the early stage of development, which assures that lineage differentiation (i.e., the ability to differentiate Paneth and goblet cells) and intestine function is not affected by KLF4 depletion. The limitation of our model is that KLF4 depletion is not complete. KLF4 is more efficiently deleted in differentiation cells, but less efficiently deleted in progenitor cells that have low levels of KLF4. The daughter cells differentiated from these progenitor cells may express high levels of KLF4. Thus, this mouse model can be used to study KLF4 function in differentiated cells, but is not suitable to study KLF4 function in cell fate determination during stem cell differentiation.
As to the function of KLF4 in cell proliferation, KLF4 plays a crucial role in maintaining the integrity of the cell cycle . Low levels of KLF4 mRNA are essential for cell proliferation . In our study, the proliferating compartment of the intestine in Klf4−/− mice was increased while the total length of the villus-crypt axis turned out to be increased as well, suggesting the role of KLF4 in inhibiting outgrowth of the intestine villus-crypt beyond normal length. The numbers of goblet cells, Paneth cells and tuft cells were increased in KLF4 depleted small intestine, further suggesting that KLF4 inhibits proliferation of certain cell types and thus contributes to maintaining normal cell populations in the intestine. KLF4 also regulates the proliferation of stem cells and/or tuft cells, as indicated by DCAMKL-1 staining (Fig. 2). In control mouse intestine, DCAMKL-1 positive cells were mainly located in the stem cell zone and amplification compartment; in Klf4−/− mouse intestine, the number of DCAMKL-1 positive cells increased significantly in both the amplification and differentiation compartments. DCAMKL-1 has been suggested to be a marker for gastrointestinal stem cells and adenoma stem cells , . However, others suggest that DCAMKL-1 only identifies tuft cells since they are not always located at the stem cell position, nor do they co-express with markers of any of the main lineages constituting the intestinal epithelium . The identity of DCAMKL-1 positive cells and the potential roles of KLF4 in intestinal stem cells remain to be determined.
Our previous work demonstrated that KLF4 crosstalks with Wnt signaling in the intestine , . Wnt signaling induces maturation of Paneth cells  and mediates cell positioning in the intestinal epithelium . The abnormal numbers and locations of Paneth cells could be partially due to enhanced Wnt signaling as a result of KLF4 depletion. The role of Wnt signaling in goblet cell is not clear. Goblet cell numbers were decreased by either activation of Wnt signaling through APC deletion or inhibition of Wnt signaling by DKK1 overexpression , . Notch signaling also regulates goblet cells . It is possible that the differentiation and proliferation of goblet cells are regulated by multiple signaling pathways and different developmental stages.
Based on the observation of changes in cell position and apical-basolateral polarity in Klf4−/− intestine epithelia, together with results from the 3D intestinal epithelial cyst formation assay, we demonstrated that KLF4 regulates intestinal epithelial cell polarity in addition to cell differentiation and proliferation, thus affecting morphology and homeostasis of the intestine.
Several genes that regulated cell polarity were repressed by KLF4, including LKB1. As a ‘master’ regulator of cell polarity, LKB1 was reported to induce complete polarity in intestinal epithelial cells; depletion of LKB1 in Caco-2 cells led to impairment of spontaneous polarization , . Recently, it was reported that that CDX2 deficiency leads to abnormal apical-basal polarity in intestinal epithelial cells  and that CDX2 deficiency leads to elevated expression of LKB1 . Since KLF4 expression is dependent on CDX2 in human colon cancer cells , our finding is consistent with these reports and suggests that KLF4 regulates cell polarity through multiple genes, including LKB1.
In summary, the results from this study and previous studies suggest that KLF4 has multiple functions. In the early embryonic stage, KLF4 induces goblet cell differentiation in intestinal epithelium; throughout intestinal development, KLF4 maintains homeostasis of normal intestinal growth and keeps epithelial cells from over-proliferation. Meanwhile, KLF4 regulates apical-basolateral polarity of the intestinal epithelial cells. After all, the intestinal homeostasis and morphology are regulated by multiple factors, including KLF4 and its target genes.
Mouse experiments were performed under the approval by the Institutional Biosafety Committee (IBC) and by the Institutional Animal Care and Use Committees (IACUC) of University of South Carolina (Proposal number 1573).
Transgenic mice were generated using a Cre recombinase derived from a bacterial artificial chromosome (BAC, RP23-322L22) containing mouse KLF4 gene . A Cre recombinase cDNA was fused with estrogen receptor gene and was inserted into KLF4 locus at the initiating codon, and the CreER gene transcription is under the control of KLF4 promoter. KLF4 knockout in KLF4/CreER (+/−)/KLF4 (flox/flox) double transgenic mice was induced by 100 mg/kg tamoxifen intraperitoneally (i.p.) for 5 consecutive days at 4 weeks old. Expression of KLF4 as well as multiple genes in wild-type (Klf4+/+) and knockout (Klf4−/−) mice was analyzed 3, 5 or 30 days after induction by immunohistochemistry (IHC) staining of fixed intestine tissues.
Caco-2 human colonic epithelial cell line  was cultured in high glucose Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. For 3D culture, approximately 1.5×105 cells were embedded into 250 µl of 80–90% matrigel. The 3D matrix was allowed to harden in a 24-well plate at 37°C for 30 minutes, then 500 µM of DMEM medium with 2% fetal bovine serum was added and cysts were allowed to form over 5–7 days at 37°C.
LS174T colon cancer cell line  was grown in RPMI medium (Mediatech) supplemented with 5% fetal bovine serum and 1% penicillin/streptomycin. Stable cell line LS174T-tet/on-KLF4 has been described previously (Zhang et al., 2006). LS174T-tet/on-KLF4 cells were plated at approximately 2×105 cells per well in a 6-well plate. The following day, doxycycline (1 µg/ml) was added to the culture medium. After 24 h of incubation, cells were trypsinized and counted, then followed by 3D formation assay as indicated with Caco-2 cells.
Cells were lysed in the appropriate volume of lysis buffer (50 mM HEPES, 100 mM NaCl, 2 mM EDTA, 1% glycerol, 50 mM NaF, 1 mM Na3VO4, 1% Triton X-100, with protease inhibitors). The following antibodies were used: mouse anti-β-Actin (Sigma, A1978), mouse anti-Flag (Sigma, F1804).
LS174T-tet/on-KLF4 cells were plated at approximately 2×105 cells per well in a 6-well plate. The following day, doxycycline (1 µg/ml) was added to the culture medium. After 48 h of incubation, RNA was isolated using the RNeasy kit (Qiagen). Reverse transcriptase PCR (RT-PCR) was performed as described previously (Zhang et al., 2006). The following primers were used: β-actin, [gene: 5′-CAACCGCGAGAAGATGAC-3′] and [gene: 5′-AGGAAGGCTGGAAGAGTG-3′]; IAP, [gene: 5′-CCATTGCCGTACAGGATGGAC-3′] and [gene: 5′-CGCGGCTTCTACCTCTTTGTG-3′]; p21Cip1/WAF1: [gene: 5′-CGACTGTGATGCGCTAATGG-3′] and [gene: 5′-AGAAGATCAGCCGGCGTTTG-3′]; LGR5: [gene: 5′-CCTGCTTGACTTTGAGGAAGAC-3′] and [gene: 5′-ATGTTCACTGCTGCGATGAC-3′]; CD44: [gene: 5′-CAGAATGGCTGATCATCTTG-3′] and [gene: 5′-CAAATGCACCATTTCCTGAG-3′]; LKB1: [gene: 5′-GAGGAGGTTACGGCACAAAA-3′] and [gene: 5′-CTGTCCAGCATTTCCTGCAT-3′]; MARK2: [gene: 5′-GCCAGAATCAAAAGCAAC] and [gene: 5′-ATGATGTTTAGTGGGAGG-3′]; BMI1: [gene: 5′-AGCAGAAATGCATCGAACAA-3′] and [gene: 5′-CCTAACCAGATGAAGTTGCTG-3′]; EPHB2: [gene: 5′-AAAATTGAGCAGGTGATCGG-3′] and [gene: 5′-TCACAGGTGTGCTCTTGGTC-3′]; EPHB3: [gene: 5′-AGCAACCTGGTCTGCAAAGT-3′] and [gene: 5′-TCCATAGCTCATGACCTCCC-3′].
Interference RNA and immunohistochemistry were tested as described previously (Zhang et al., 2006). Lentiviral stocks were prepared using control shRNA or human KLF4 shRNA on pGIPz vector containing a marker of turbo GFP (Open Biosystems). H&E staining was performed based on standard protocol by Histology Laboratory of the Imaging Facility at University of Kentucky.
For immunohistochemistry staining, the following antibodies were used: KLF4 (Zhang et al., 2006), rabbit anti-human Lysozyme (Diagnostic BioSystems, RP 028-05), rabbit anti-DCAMKL-1 (Abgent, AP7219b), rabbit anti-Ki67 (Novus Biologicals, NB110-89717).
PAS staining was performed based on standard protocol using reagents of PAS Staining System from Sigma (395-B). Alcian Blue (AB) staining was performed according to standard protocol using Alcian Blue 8GX and Fast Red from Sigma (kindly provided by Dr. Tianyan Gao).
Cells grown on cover glass were fixed in 4% paraformaldehyde in PBS at room temperature for 15 min, washed 3 times with PBS, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and then blocked in 5% goat serum in PBS at room temperature for 1 h. Cells were incubated with primary antibodies at room temperature for 2 hours. Antibodies used include rat anti-human CD49f (α6-integrin, BD Pharmingen, 555734) and rabbit anti-ZO-1 (Invitrogen, 61-7300). Then cells were washed 3 times with PBS and further incubated with Alexa-488-labeled anti-rat IgG (1∶500) and Alexa-568-labeled anti-Rabbit IgG (1∶500) diluted in PBS for 40 min. Nuclei were stained by DAPI (Sigma). The cover glasses were washed, mounted on glass slides, viewed and photographed with an Olympus FW1000 confocal microscope.
Competing Interests: The authors have declared that no competing interests exist.
Funding: CL was supported by R01 DK071976 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
We thank Drs. B. Mark Evers, Jing Li and Jiandang Shi for suggestions and technical assistance, Tianyan Gao for reagents and Cynthia Long for H&E staining of mouse tissues.
|1.||Ghaleb AM,McConnell BB,Kaestner KH,Yang VW. Year: 2010Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Kruppel-like factor 4 gene.Dev Biol|
|2.||Jemal A,Siegel R,Ward E,Hao Y,Xu J,et al. Year: 2009Cancer statistics, 2009.CA Cancer J Clin5922524919474385|
|3.||Jemal A,Siegel R,Ward E,Murray T,Xu J,et al. Year: 2006Cancer statistics, 2006.CA Cancer J Clin5610613016514137|
|4.||Kinzler KW,Vogelstein B. Year: 1996Lessons from hereditary colorectal cancer.Cell871591708861899|
|5.||Polakis P. Year: 2000Wnt signaling and cancer.Genes Dev141837185110921899|
|6.||Giles RH,van Es JH,Clevers H. Year: 2003Caught up in a Wnt storm: Wnt signaling in cancer.Biochim Biophys Acta165312412781368|
|7.||Shields JM,Christy RJ,Yang VW. Year: 1996Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest.J Biol Chem27120009200178702718|
|8.||Garrett-Sinha LA,Eberspaecher H,Seldin MF,de Crombrugghe B. Year: 1996A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells.J Biol Chem27131384313908940147|
|9.||Panigada M,Porcellini S,Sutti F,Doneda L,Pozzoli O,et al. Year: 1999GKLF in thymus epithelium as a developmentally regulated element of thymocyte-stroma cross-talk.Mech Dev8110311310330488|
|10.||Chiambaretta F,De Graeve F,Turet G,Marceau G,Gain P,et al. Year: 2004Cell and tissue specific expression of human Kruppel-like transcription factors in human ocular surface.Mol Vis1090190915570219|
|11.||Cullingford TE,Butler MJ,Marshall AK,Tham el L,Sugden PH,et al. Year: 2008Differential regulation of Kruppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: effects of endothelin-1, oxidative stress and cytokines.Biochim Biophys Acta17831229123618406357|
|12.||Fruman DA,Ferl GZ,An SS,Donahue AC,Satterthwaite AB,et al. Year: 2002Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes.Proc Natl Acad Sci U S A9935936411756681|
|13.||Ton-That H,Kaestner KH,Shields JM,Mahatanankoon CS,Yang VW. Year: 1997Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis.FEBS Lett4192392439428642|
|14.||Katz JP,Perreault N,Goldstein BG,Lee CS,Labosky PA,et al. Year: 2002The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon.Development1292619262812015290|
|15.||Ghaleb AM,McConnell BB,Kaestner KH,Yang VW. Year: 2011Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Kruppel-like factor 4 gene.Dev Biol34931032021070761|
|16.||Evans PM,Chen X,Zhang W,Liu C. Year: 2010KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin.Mol Cell Biol3037238119901072|
|17.||Zhao W,Hisamuddin IM,Nandan MO,Babbin BA,Lamb NE,et al. Year: 2004Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer.Oncogene2339540214724568|
|18.||Zhang W,Chen X,Kato Y,Evans PM,Yuan S,et al. Year: 2006Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression.Mol Cell Biol262055206416507986|
|19.||Ghaleb AM,McConnell BB,Nandan MO,Katz JP,Kaestner KH,et al. Year: 2007Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.Cancer Res677147715417671182|
|20.||Takahashi K,Tanabe K,Ohnuki M,Narita M,Ichisaka T,et al. Year: 2007Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell13186187218035408|
|21.||Takahashi K,Yamanaka S. Year: 2006Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell12666367616904174|
|22.||Pellegrinet L,Rodilla V,Liu Z,Chen S,Koch U,et al. Year: 2011Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells.Gastroenterology14012301240e1231–123721238454|
|23.||Maunoury R,Robine S,Pringault E,Leonard N,Gaillard JA,et al. Year: 1992Developmental regulation of villin gene expression in the epithelial cell lineages of mouse digestive and urogenital tracts.Development1157177281425351|
|24.||Juan Li HZ,Yu Fang,Yu Tianxin,ChunmingLiu,Huang Shiang,Wang TimothyC,Ai Walden. Year: 2011Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis.Neoplasia Submitted.|
|25.||Chen X,Yang J,Evans PM,Liu C. Year: 2008Wnt signaling: the good and the bad.Acta Biochim Biophys Sin (Shanghai)4057759418604449|
|26.||Pinto D,Clevers H. Year: 2005Wnt, stem cells and cancer in the intestine.Biol Cell9718519615715524|
|27.||Gerbe F,Brulin B,Makrini L,Legraverend C,Jay P. Year: 2009DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium.Gastroenterology13721792180; author reply 2180-217119879217|
|28.||May R,Riehl TE,Hunt C,Sureban SM,Anant S,et al. Year: 2008Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice.Stem Cells2663063718055444|
|29.||May R,Sureban SM,Hoang N,Riehl TE,Lightfoot SA,et al. Year: 2009Doublecortin and CaM Kinase-like-1 and Leucine-Rich-Repeat-Containing G-Protein-Coupled Receptor Mark Quiescent and Cycling Intestinal Stem Cells, Respectively.Stem Cells272571257919676123|
|30.||Ghaleb AM,Nandan MO,Chanchevalap S,Dalton WB,Hisamuddin IM,et al. Year: 2005Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation.Cell Res15929615740636|
|31.||van Es JH,Jay P,Gregorieff A,van Gijn ME,Jonkheer S,et al. Year: 2005Wnt signalling induces maturation of Paneth cells in intestinal crypts.Nat Cell Biol738138615778706|
|32.||Batlle E,Henderson JT,Beghtel H,van den Born MM,Sancho E,et al. Year: 2002Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.Cell11125126312408869|
|33.||Sansom OJ,Reed KR,Hayes AJ,Ireland H,Brinkmann H,et al. Year: 2004Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.Genes Dev181385139015198980|
|34.||Pinto D,Gregorieff A,Begthel H,Clevers H. Year: 2003Canonical Wnt signals are essential for homeostasis of the intestinal epithelium.Genes Dev171709171312865297|
|35.||Baas AF,Kuipers J,van der Wel NN,Batlle E,Koerten HK,et al. Year: 2004Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD.Cell11645746615016379|
|36.||Baas AF,Smit L,Clevers H. Year: 2004LKB1 tumor suppressor protein: PARtaker in cell polarity.Trends Cell Biol1431231915183188|
|37.||Grainger S,Savory JG,Lohnes D. Year: 2010Cdx2 regulates patterning of the intestinal epithelium.Dev Biol33915516520043902|
|38.||Gao N,Kaestner KH. Year: 2010Cdx2 regulates endo-lysosomal function and epithelial cell polarity.Genes Dev241295130520551175|
|39.||Dang DT,Mahatan CS,Dang LH,Agboola IA,Yang VW. Year: 2001Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2.Oncogene204884489011521200|
|40.||Lee EC,Yu D,Martinez de Velasco J,Tessarollo L,Swing DA,et al. Year: 2001A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA.Genomics73566511352566|
|41.||Wang Q,Wang X,Hernandez A,Hellmich MR,Gatalica Z,et al. Year: 2002Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.J Biol Chem277366023661012140294|
Previous Document: Revisiting gender differences in somatic symptoms of depression: much ado about nothing?
Next Document: Sample preparation and liquid chromatography-tandem mass spectrometry for multiple steroids in mamma...